ALDH3A1 inhibitors such as dyclonine, CB7, and CB29 have all been shown to enhance cancer cell sensitivity to sulfasalazine and cyclophosphamide, respectively [60,61,62]. The gene discussed is ALDH3A1; the disease is cancer.